J. Chalopin

A. Kazory, C. Courivaud, D. Ducloux, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1997, Transplantation.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1998 .

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients

M. Deschamps, P. Tiberghien, P. Saas, 2011, Journal of Transplantation.

Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.

R. Gibey, B. Challier, D. Ducloux, 2000, Journal of the American Society of Nephrology : JASN.

Miller-Fisher syndrome and pontine abnormalities on MRI: a case report

M. Giroud, G. Rifle, C. Mousson, 1990, Journal of Neurology.

No evidence of association between NOD 2 / CARD 15 gene polymorphism and atherosclerotic events after renal transplantation

M. Deschamps, C. Ferrand, A. Duperrier, 2017 .

Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation

P. Saas, B. Gaugler, C. Courivaud, 2015, Transplantation.

No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2006, Transplantation.

Impact of malnutrition-inflammation on the association between homocysteine and mortality.

A. Kazory, D. Ducloux, N. Devillard, 2006, Kidney international.

Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2014, Journal of the American Society of Nephrology : JASN.

Long‐term follow‐up of renal transplant recipients treated with losartan for post‐transplant erythrosis

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998 .

Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysis patients.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2013, The Journal of infectious diseases.

Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.

G. Toubin, Z. Massy, T. Drüeke, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts: serial baroreflex responses

J. Fortrat, J. Regnard, M. Bouhaddi, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Six‐month cardiovascular changes in cyclosporine‐treated recipients of corneal grafts: serial baroreflex responses

J. Fortrat, J. Regnard, M. Bouhaddi, 2004 .

Homocysteine, nutritional status and insulin in renal transplant recipients.

R. Gibey, D. Ducloux, J. Chalopin, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma exchange in central nervous system involvement of systemic lupus erythematosus

G. Rifle, C. Mousson, J. Chalopin, 1987 .

Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients.

D. Ducloux, J. Chalopin, G. Motte, 2003, Kidney international.

Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids

F. Berthoux, L. Rostaing, P. Lang, 2010, Transplantation.

Significant increase in 1-year posttransplant renal arterial index predicts graft loss.

B. Kastler, C. Courivaud, D. Ducloux, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Systemic lupus erythematosus occurring in a patient with multiple myeloma.

E. Solary, D. Caillot, N. Olsson, 1986, Arthritis and rheumatism.

Effect of losartan on haemoglobin concentration in renal transplant recipients--a retrospective analysis.

D. Ducloux, J. Chalopin, Y. Saint-Hillier, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Postrenal transplant erythrosis: a direct role for angiotensin II.

D. Ducloux, J. Chalopin, V. Fournier, 1997, Clinical nephrology.

Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2‐year follow‐up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002 .

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report.

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 1998, Transplantation.

G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation.

P. Tiberghien, E. Thervet, P. Saas, 2009, Transplantation.

Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1998, Clinical nephrology.

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2005, Kidney international.

No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.

C. Bresson, J. Regnard, M. Bouhaddi, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Chronic congestive heart failure associated with bilateral renal artery stenosis.

D. Ducloux, J. Chalopin, M. Jamali, 1997, Clinical nephrology.

Losartan decreases hemoglobin in renal transplant recipients.

D. Ducloux, J. Chalopin, 1997, Transplantation proceedings.

Treatment of posttransplant erythrocytosis with losartan.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Transplantation proceedings.

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients.

F. Aubin, P. Carron, P. Humbert, 1998, Transplantation.

Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein.

J. Liepnieks, M. Benson, D. Droz, 1997, Blood.

The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins.

P. Tiberghien, C. Ferrand, P. Saas, 2011, Human immunology.

Impact of pre‐transplant dialysis modality on post‐transplant diabetes mellitus after kidney transplantation

P. Rieu, O. Toupance, L. Frimat, 2011, Clinical transplantation.

LONG-TERM TOXICITY OF ANTITHYMOCYTE GLOBULIN INDUCTION MAY VARY WITH CHOICE OF AGENT: A SINGLE-CENTER RETROSPECTIVE STUDY

A. Kazory, B. Challier, D. Ducloux, 2004, Transplantation.

Hypertension in renal transplantation: donor and recipient risk factors.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2002, Clinical nephrology.

Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantation.

F. Aubin, M. Deschamps, P. Tiberghien, 2010, The Journal of investigative dermatology.

Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.

C. Billerey, D. Ducloux, J. Chalopin, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection *

P. Tiberghien, C. Ferrand, A. Duperrier, 2006, Transplant international : official journal of the European Society for Organ Transplantation.

Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis.

S. Semhoun-Ducloux, D. Ducloux, C. Bresson‐Vautrin, 1998, Transplantation.

Treatment of idiopathic acute crescentic glomerulonephritis by immunodepression and plasma-exchanges. A prospective randomised study.

P. Vialtel, P. Zech, P. Deteix, 1981, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

P. Tiberghien, P. Carron, D. Ducloux, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Cutaneous Alternaria infection in renal transplant recipients: a report of two cases with an unusual mode of transmission

R. Piarroux, G. Reboux, A. Kazory, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases.

A. Kazory, A. Coaquette, D. Ducloux, 2004, Transplantation.

Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure.

E. Justrabo, G. Rifle, C. Mousson, 1993, Nephron.

INTERACTION BETWEEN CEPHALOSPORINS AND ALCOHOL

M. Freysz, J. Chalopin, H. Portier, 1980, The Lancet.

T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies

P. Carron, E. Racadot, D. Ducloux, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Rheumatoid purpura associated with toxocariasis.

L. Millon, P. Humbert, J. Bamoulid, 2011, Canadian family physician Medecin de famille canadien.

One‐Year Post‐Transplant Weight Gain is a Risk Factor for Graft Loss

A. Kazory, D. Ducloux, J. Chalopin, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[Treatment of refractory congestive cardiac insufficiency by continuous peritoneal dialysis. Long-term course].

G. Rifle, C. Mousson, G. Dentan, 1988, Presse medicale.

Immunological findings during successful treatment of HBsAg-associated polyartheritis nodosa by plasmapheresis alone.

G. Rifle, J. Chalopin, M. Severac, 1980, British medical journal.

Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation

I. Dupont, D. Alcalay, P. Tiberghien, 2002, Transplantation.

Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2010, Journal of the American Society of Nephrology : JASN.

Anti-class II antibodies in kidney transplant patients.

P. Tiberghien, P. Hervé, D. Ducloux, 2000, Transplantation proceedings.

Mycophenolate mofetil in cyclosporine-associated nephrotoxicity.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998, Transplantation proceedings.

Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.

P. Tiberghien, C. Borg, C. Ferrand, 2011, Transplant immunology.

CD4 lymphocytopenia in long-term renal transplant recipients.

P. Carron, E. Racadot, D. Ducloux, 1998, Transplantation proceedings.

A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.

M. Mihatsch, E. Thervet, C. Legendre, 2000, Transplantation Proceedings.

Polycystic kidney size and outcomes on peritoneal dialysis: comparison with haemodialysis

É. Delabrousse, C. Courivaud, D. Ducloux, 2014, Clinical kidney journal.

Treatment of metformin-associated lactic acidosis with closed recirculation bicarbonate-buffered hemodialysis.

J. Besancenot, G. Rifle, J. Cabanne, 1984, Archives of internal medicine.

Late 'spontaneous' kidney graft decapsulation with fluid collection: lymphocele or transudate?

G. Rifle, C. Mousson, J. Chalopin, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Colchicine myopathy in renal transplant recipients on cyclosporin.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Is cytomegalovirus a cause of ureteral stricture in renal transplant recipients?

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Metabolic Syndrome and Atherosclerotic Events in Renal Transplant Recipients

A. Kazory, C. Courivaud, D. Ducloux, 2007, Transplantation.

Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Silicosis associated with crescentic IgA mesangial nephropathy.

A. Bonnin, E. Justrabo, G. Rifle, 1987, Nephron.

T‐cell immune defect and B‐cell activation in renal transplant recipients with monoclonal gammopathies

P. Carron, E. Racadot, D. Ducloux, 1999 .

C-reactive protein and cardiovascular disease in peritoneal dialysis patients.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2002, Kidney international.

Plasma exchange and an immunosuppressive regimen in primary biliary cirrhosis.

P. Hillon, G. Rifle, C. Mousson, 1990, Progress in clinical and biological research.

Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.

B. Chauffert, X. Pivot, B. Royer, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Successful plasma exchange in type 1 leprosy reversal reaction.

F. Lucht, G. Rifle, J. Chalopin, 1984, British medical journal.

Posttransplant Diabetes Mellitus and Atherosclerotic Events in Renal Transplant Recipients: A Prospective Study

A. Kazory, D. Ducloux, J. Chalopin, 2005, Transplantation.

Predicting coronary heart disease in renal transplant recipients: a prospective study.

A. Kazory, D. Ducloux, J. Chalopin, 2004, Kidney international.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1997, Transplantation.

Cyclosporine withdrawal in stable renal transplant recipients after azathioprine‐mycophenolate mofetil conversion

M. Mihatsch, E. Thervet, A. Janin, 2000, Clinical transplantation.

IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2006, Journal of the American Society of Nephrology : JASN.

Use of pentoxifylline in membranous nephropathy

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2001, The Lancet.

[Acute granulomatous interstitial nephritis and hepatitis caused by drugs. Possible role of an allopurinol-furosemide combination].

E. Justrabo, G. Rifle, C. Mousson, 1986, Nephrologie.

Disseminated aspergillosis revealed by thyroiditis in a renal allograft recipient.

E. Solary, E. Justrabo, G. Rifle, 1987, Transplantation.

Atheroembolic disease associated with the use of low-molecular-weight heparin during haemodialysis.

P. Carron, D. Ducloux, J. Chalopin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hospital costs of renal transplant management.

H. Bittard, A. Dussaucy, S. Limat, 2008, Transplantation proceedings.

[Letter: Membrano-proliferative, complement-deficient glomerulonephritis in myeloma. Preliminary note].

G. Rifle, J. Chalopin, R. Génin, 1976, La Nouvelle presse medicale.

Variations of sotalol kinetics in renal insufficiency.

J. Besancenot, G. Rifle, P. D'athis, 1989, International journal of clinical pharmacology, therapy, and toxicology.

Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine.

G. Mantion, J. Miguet, S. Semhoun-Ducloux, 2000, Transplantation proceedings.

Homocysteine in renal disease.

D. Ducloux, J. Chalopin, G. Motte, 2000, Clinical Laboratory.

Plasmapheresis in the treatment of renal allograft rejections.

P. Vialtel, G. Rifle, D. Cordonnier, 1979, Transplantation proceedings.

Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?

R. Gibey, D. Ducloux, J. Chalopin, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients.

G. Toubin, Aboubakr Abdelfatah, Didier Ducloux, 2002, Transplantation.

Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.

G. de‐Thé, J. Revillard, J. Lamelin, 1977, British Journal of Cancer.

COLD LYMPHOCYTOTOXIC ANTIBODIESIN NASOPHARYNGEAL CARCINOMA

J. Revillard, J. Lamelin, J. Chalopin, 1977 .

Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion

J. Rémy-Martin, P. Tiberghien, C. Ferrand, 2006, Cell Death and Differentiation.

ATG‐Induced Accelerated Immune Senescence: Clinical Implications in Renal Transplant Recipients

P. Rieu, P. Tiberghien, C. Ferrand, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ocular Venous Occlusion and Hyperhomocysteinemia

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1999, Annals of Internal Medicine.

Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Non-Dialysis Chronic Renal Insufficiency study (ND-CRIS): an open prospective hospital-based cohort study in France

J. Massol, G. Janin, J. Chalopin, 2016, BMC Nephrology.